Arkolith/Insider Trading/PMN/Form 4

Cashman Neil

Chief Scientific Officer, DirectorProMIS Neurosciences Inc. (PMN) · full profile →Form 4 · filed Feb 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 3, 2026Grant(A)4K$12.13$50K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 3, 2026Grant(A)4K——4K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-011140) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML